PTK2 and neoplasm: Given the evidence of Pyk2 and FAK expression in myeloid cells [49], PF-562271 may also impair the migratory capabilities of these cells, preventing significant infiltration into the tumor resection site and reducing the TIM component involved in tumor recurrence.